These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6469510)
1. Macromolecular DNA-damage in murine and human leukemic and lymphoid cells after in vitro exposure to ASTA Z 7557 (INN mafosfamide). Osieka R; Pannenbäcker R; Schmidt CG Invest New Drugs; 1984; 2(2):161-8. PubMed ID: 6469510 [TBL] [Abstract][Full Text] [Related]
2. Interactions of mitomycin C with mammalian DNA detected by alkaline elution. Dorr RT; Bowden GT; Alberts DS; Liddil JD Cancer Res; 1985 Aug; 45(8):3510-6. PubMed ID: 3926301 [TBL] [Abstract][Full Text] [Related]
3. Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells. Hilton J Biochem Pharmacol; 1984 Jun; 33(12):1867-72. PubMed ID: 6732847 [TBL] [Abstract][Full Text] [Related]
4. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells. DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro. Erickson LC; Ramonas LM; Zaharko DS; Kohn KW Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062 [TBL] [Abstract][Full Text] [Related]
6. Differential cytotoxicity and DNA cross-linking produced by polymeric and monomeric activated analogues of cyclophosphamide in mouse L1210 leukemia cells. Ramonas LM; Erickson LC; Klesse W; Kohn KW; Zaharko DS Mol Pharmacol; 1981 Mar; 19(2):331-6. PubMed ID: 7231393 [No Abstract] [Full Text] [Related]
7. Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links. Ross WE; Ewig RA; Kohn KW Cancer Res; 1978 Jun; 38(6):1502-6. PubMed ID: 565677 [TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide). Alberts DS; Einspahr JG; Struck R; Bignami G; Young L; Surwit EA; Salmon SE Invest New Drugs; 1984; 2(2):141-8. PubMed ID: 6469507 [TBL] [Abstract][Full Text] [Related]
9. Effect of carbamoylation on the repair of nitrosourea-induced DNA alkylation damage in L1210 cells. Heal JM; Fox PA; Schein PS Cancer Res; 1979 Jan; 39(1):82-9. PubMed ID: 153789 [No Abstract] [Full Text] [Related]
10. Relationship between cytotoxicity and DNA strand breakage produced by adriamycin and other intercalating agents. Ross WE; Zwelling LA; Kohn KW Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1221-4. PubMed ID: 528266 [No Abstract] [Full Text] [Related]
11. The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells. Strandberg MC; Bresnick E; Eastman A Chem Biol Interact; 1982 Mar; 39(2):169-80. PubMed ID: 7199396 [TBL] [Abstract][Full Text] [Related]
12. DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Hilton J; Bowie DL; Gutin PH; Zito DM; Walker MD Cancer Res; 1977 Jul; 37(7 Pt 1):2262-6. PubMed ID: 861950 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the DNA damage in 6-thioguanine-treated cells. Pan BF; Nelson JA Biochem Pharmacol; 1990 Sep; 40(5):1063-9. PubMed ID: 2390103 [TBL] [Abstract][Full Text] [Related]
14. DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Zwelling LA; Anderson T; Kohn KW Cancer Res; 1979 Feb; 39(2 Pt 1):365-9. PubMed ID: 570092 [TBL] [Abstract][Full Text] [Related]
15. DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas. Ewig RA; Kohn KW Cancer Res; 1977 Jul; 37(7 Pt 1):2114-22. PubMed ID: 558823 [No Abstract] [Full Text] [Related]
16. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines. Sladek NE; Landkamer GJ Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623 [TBL] [Abstract][Full Text] [Related]
17. New application of a stabilized active cyclophosphamide derivative (mafosfamide, ASTA Z 7654)--immunogenic properties of lymphatic leukemia L 1210 cells treated in vitro with the drug. Skórski T; Kawalec M Invest New Drugs; 1987; 5(2):167-9. PubMed ID: 3654151 [TBL] [Abstract][Full Text] [Related]
18. Observations on the effects of cyclophosphamide, phosphoramide mustard and some activated oxazaphosphorines on murine L1210 leukemia. Zaharko DS; Covey JM; Hörpel G Invest New Drugs; 1984; 2(2):149-54. PubMed ID: 6469508 [TBL] [Abstract][Full Text] [Related]
19. cis-Diamminedichloroplatinum(II) (DDP)-induced crosslinking and crosslink removal in L1210 cells in vitro after theophylline co-treatment. Ducore JM Biochem Pharmacol; 1986 Feb; 35(4):607-11. PubMed ID: 3947390 [TBL] [Abstract][Full Text] [Related]
20. In vitro chemosensitivity of leukemic progenitor cells (AML-CFU) to a combination of mafosfamide lysine (ASTA-Z 7654) and etoposide (VP16-213). Deconinck E; Tamayo E; Hervé P Bone Marrow Transplant; 1990 Jan; 5(1):13-8. PubMed ID: 2297586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]